Related Experiment Videos

A preliminary study of microcapsule suspension for hemolysis evaluation of artificial organs

O Maruyama1, T Yamane, N Tsunemoto

  • 1Mechanical Engineering Laboratory, University of Tsukuba, Japan. maru@mel.go.jp

Artificial Organs
|April 13, 1999
PubMed

Insights

A novel microcapsule suspension offers a viable alternative to animal blood for hemolysis testing of artificial organs. This blood substitute demonstrates similar results to animal blood, aiding in the evaluation of circulatory device performance.

Area of Science:

  • Biomaterials Science
  • Medical Device Engineering
  • Hemolysis Testing

Background:

  • Hemolysis testing is crucial for evaluating the biocompatibility of circulatory artificial organs.
  • Animal blood is traditionally used, but ethical and practical concerns exist.
  • A reliable blood substitute is needed for consistent and ethical hemolysis evaluation.

Purpose of the Study:

  • To develop and evaluate a microcapsule suspension as a substitute for animal blood in hemolysis tests.
  • To assess the hemolytic properties of circulatory artificial organs using the developed microcapsule suspension.
  • To compare the performance of the microcapsule suspension with animal blood in hemolysis tests.

Main Methods:

  • A microcapsule suspension was prepared using polyurethane membranes encapsulating a leuco dye.
  • The microcapsules were dispersed in an ethylene glycol sodium chloride solution.
  • Hemolysis was assessed by measuring leuco dye release after microcapsule destruction and comparing pump performance with bovine blood.

Main Results:

  • The microcapsule suspension exhibited Newtonian fluid characteristics with a viscosity of approximately 5.8 mPa.s.
  • Microcapsule destruction patterns correlated with hemolysis mechanisms observed in biological membranes.
  • Tests with centrifugal blood pumps showed comparable results to those using bovine blood, indicating the suspension's efficacy.

Conclusions:

  • The developed microcapsule suspension serves as a promising alternative to animal blood for hemolysis testing.
  • This blood substitute enables accurate evaluation of circulatory artificial organ performance.
  • The microcapsule suspension provides results similar to animal blood, supporting its use in device development.

Related Concept Videos